Develops drugs for liver diseases and viral infections.
Jun 2026Revenue $3.74M/yrExpenses $82.7M/yr
No trendCash runway ≈ 4 months from Jun 2026
Figures by year
When will Aligos Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $3.74M and expenses $82.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.19M | $90.2M | −$88.0M |
| Dec 2024 | $3.61M | $92.8M | −$89.2M |
| Dec 2023 | $6.19M | $94.3M | −$88.1M |
| Dec 2022 | $0.00 | $97.6M | −$97.6M |
| Dec 2021 | $0.00 | $128M | −$128M |
| Dec 2020 | $0.00 | $97.8M | −$97.8M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.